First Manhattan CO Ani Pharmaceuticals Inc Transaction History

First Manhattan CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $8.08 Million - $13.5 Million	-269,876 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$30.35 - $67.14 $497,831 - $1.1 Million	16,403 Added 6.47%	269,876 $11 Million
Q3 2019 Nov 13, 2019	SELL	$64.7 - $85.39 $2.68 Million - $3.53 Million	-41,379 Reduced 14.03%	253,473 $18.5 Million
Q2 2019 Aug 16, 2019	BUY	$67.77 - $82.2 $3.71 Million - $4.5 Million	54,686 Added 22.77%	294,852 $24.2 Million
Q1 2019 Apr 12, 2019	BUY	$45.83 - $70.54 $236,986 - $364,762	5,171 Added 2.2%	240,166 $16.9 Million
Q4 2018 Jan 30, 2019	BUY	$41.17 - $56.44 $794,581 - $1.09 Million	19,300 Added 8.95%	234,995 $10.6 Million
Q3 2018 Oct 15, 2018	BUY	$52.95 - $71.34 $3.71 Million - $4.99 Million	70,000 Added 48.05%	215,695 $12.2 Million
Q4 2017 Jan 22, 2018	SELL	$53.3 - $74.56 $12.1 Million - $17 Million	-227,900 Reduced 61.0%	145,695 $9.39 Million
Q3 2017 Oct 25, 2017	BUY	$43.46 - $52.49 $16.2 Million - $19.6 Million	373,595	373,595 $19.6 Million

213

18.6M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.